Deutsche Bank reissued their neutral rating on shares of Gerresheimer (ETR:GXI) in a research note issued to investors on Friday.

A number of other brokerages also recently weighed in on GXI. Hauck & Aufhaeuser set a €55.00 ($67.90) target price on Gerresheimer and gave the company a sell rating in a report on Wednesday, January 24th. Independent Research set a €74.00 ($91.36) price target on Gerresheimer and gave the company a neutral rating in a research note on Thursday, January 25th. Goldman Sachs set a €68.00 ($83.95) price target on Gerresheimer and gave the company a neutral rating in a research note on Thursday, January 25th. equinet set a €75.00 ($92.59) price target on Gerresheimer and gave the company a neutral rating in a research note on Friday, January 19th. Finally, JPMorgan Chase set a €87.70 ($108.27) price target on Gerresheimer and gave the company a buy rating in a research note on Thursday, January 4th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of €67.96 ($83.90).

How to Become a New Pot Stock Millionaire

Shares of GXI opened at €66.80 ($82.47) on Friday. Gerresheimer has a fifty-two week low of €59.97 ($74.04) and a fifty-two week high of €78.25 ($96.60).

WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/04/16/deutsche-bank-reaffirms-neutral-rating-for-gerresheimer-gxi.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.